home / stock / ctlt / ctlt articles

CTLT Articles, Catalent Inc. - From 02/28/24

Stock Information
Company Name: Catalent Inc.
Stock Symbol: CTLT
Market: NYSE
Website: catalent.com
Menu
CTLT CTLT Quote CTLT Short CTLT News CTLT Articles CTLT Message Board
Get CTLT Alerts

News, Short Squeeze, Breakout and More Instantly...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, FREE, NGM | Benzinga

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors | Benzinga

The race for new drugs to fight obesity and associated diabetes and cardiovascular diseases heated up on Monday after positive results from trials ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT | Benzinga

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Catalent, Inc. ("Catalent" or the "...

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KNTE, CTLT | Benzinga

NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potentia...
Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs | Benzinga

The unprecedented demand for weight loss drugs, including Novo Nordisk A/S’s (NYSE:NVO) Wegovy and Eli Lilly And Co’s&nb...

US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March | Benzinga

The resilient U.S. stock market is on track to close the week on a positive note as futures pointed to a modestly higher open on Friday, with the s...

Catalent's Bloomington Plant Making Novo Nordisk's Obesity Drug Faces FDA Scrutiny Regarding Drug Manufacturing Concerns | Benzinga

Novo Nordisk A/S (NYSE:NVO) has encountered manufacturing challenges and drug shortages for its diabetes and weight loss drugs due to unpreced...
CTLT Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Catalent, Inc. for Potential Securities Law Violations | Benzinga

MONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE:CTLT) ("Ca...

Kuehn Law Encourages ZFOX, CTLT, SLAM, and EVBG Investors to Contact Law Firm | Benzinga

NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the...

Catalent Analysts Raise Their Forecasts Following Acquisition News | Benzinga

On Monday, Catalent, Inc. (NYSE: CTLT) announced it will be acquired by Novo Holdings. Novo Holdings will acquire all outstanding shares of Catal...
Previous 10 Next 10